GlassScriptPhysician profile
Joseph T Ho
NPI 1285856609
$9,599.70
in general payments reported to CMS, 2019-2025
51 companies · $419 in 2025
The $419 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,046 · 2020: $793 · 2021: $2,363 · 2022: $1,105 · 2023: $1,153 · 2024: $1,720 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,088 · Consulting Fee: $1,200 · Travel and Lodging: $4.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,087.95 |
| Consulting Fee | $1,200.00 |
| Travel and Lodging | $4.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,550.94 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Ibsa Pharma INC. | $1,517.82 | 2023-2025 | Licart, Tirosint, Licart |
| Biohaven Pharmaceuticals, INC. | $1,499.91 | 2020-2021 | |
| Medtronic USA, INC. | $451.81 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $447.98 | 2019-2025 | Xtampza, Belbuca |
| Daiichi Sankyo INC. | $443.37 | 2019 | |
| Boston Scientific Corporation | $377.24 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $350.81 | 2019 | |
| Abbvie INC. | $325.12 | 2021-2025 | |
| Lilly USA, LLC | $306.59 | 2019-2022 | |
| Spr Therapeutics, INC | $235.93 | 2022 | |
| Biodelivery Sciences International, INC. | $216.60 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $212.33 | 2022 | |
| Pfizer INC. | $182.89 | 2023-2025 | |
| Radius Health, INC. | $138.47 | 2019 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.